Publications for Alice Gottlieb

NYMC School of Medicine
  • Gottlieb, A. B., Blauvelt, A., Prinz, J. C., Papanastasiou, P., Pathan, R., Nyirady, J., . . . Papavassilis, C. (2016). Secukinumab self-administration by prefilled syringe maintains reduction of plaque psoriasis severity over 52 weeks: Results of the FEATURE trial. Journal of Drugs in Dermatology, 15(10), 1226-1234. This material can be found here.

  • Gottlieb, A., Menter, A., Armstrong, A., Ocampo, C., Gu, Y., & Teixeira, H. D. (2016). Adalimumab treatment in women with moderate-to-severe hidradenitis suppurativa from the placebo-controlled portion of a phase 2, randomized, double-blind study. Journal of Drugs in Dermatology, 15(10), 1192-1196. This material can be found here.

  • Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., . . . Gottlieb, A. B. (2016). Psoriasis. Nature Reviews. Disease Primers, 2, 16082. doi:10.1038/nrdp.2016.82

  • Kurayev, A., & Gottlieb, A. (2016). Candida esophagitis associated with mycophenolate mofetil treatment of atopic dermatitis. Journal of Drugs in Dermatology, 15(10), 1267-1269. This material can be found here.

  • Mease, P. J., Gottlieb, A. B., Berman, A., Drescher, E., Xing, J., Wong, R., & Banerjee, S. (2016). The efficacy and safety of clazakizumab, an anti-interleukin-6 monoclonal antibody, in a phase IIb study of adults with active psoriatic arthritis. Arthritis & Rheumatology, 68(9), 2163-2173. doi:10.1002/art.39700